Form 424B3 Pulmatrix, Inc.
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260925/AB2ZI22CZZ2RG2QD229Q2WY2HMWSZZ22ZV82
Filed on: September 25, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria
- WeAreDevelopers World Congress Brings the Who's Who of the Software Industry to San José in Its North America Debut
- FDA approves Lilly's Olumiant (baricitinib) for pediatric patients 12 years of age and older with severe alopecia areata
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
